StonvexLoading…
StonvexStonvexStonvexCore line items from BSX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.07B | $16.75B | $14.24B | $12.68B |
Operating Income | $3.61B | $2.60B | $2.34B | $1.65B |
Net Income | $2.89B | $1.85B | $1.59B | $698.00M |
EPS (Diluted) | $1.94 | $1.25 | $1.07 | $0.45 |
Total Assets | $43.67B | $39.40B | $35.14B | $32.47B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.97B | $414.00M | $865.00M | $928.00M |
Free Cash Flow OCF − CapEx | $3.66B | $2.65B | $1.79B | $938.00M |
Shares Outstanding | 1.49B | 1.49B | 1.46B | 1.44B |